Literature DB >> 3435842

Systemic ketamine blocks cortical spreading depression but does not delay the onset of terminal anoxic depolarization in rats.

J Hernándéz-Cáceres1, R Macias-González, G Brozek, J Bures.   

Abstract

Ketamine (KET)-induced blockade of cortical spreading depression (CSD) was examined in rats (n = 51) anesthetized with pentobarbital (50 mg/kg). CSD was elicited by intracortical injection of 1 microliter of 0.15 mol/l potassium acetate 10-40 min after i.p. injection of 6-50 mg/kg KET. KET was almost ineffective at 6 mg/kg but prevented CSD propagation at 12 mg/kg and at higher dosages. The blockade was maximal 20 min after injection. Terminal anoxic depolarization elicited by N2 breathing developed in control rats after a latency which was not significantly different from that in rats pretreated with 50 and 100 mg/kg KET. The failure of CSD blocking dosages of KET to delay the onset of terminal anoxic depolarization indicates that excitotoxic amino acids play different roles in the mechanism of the anoxia-elicited and CSD-related autoregenerative ionic shifts.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3435842     DOI: 10.1016/0006-8993(87)91652-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  28 in total

1.  Osmotic forces and gap junctions in spreading depression: a computational model.

Authors:  B E Shapiro
Journal:  J Comput Neurosci       Date:  2001 Jan-Feb       Impact factor: 1.621

Review 2.  'Spreading depression of Leão' and its emerging relevance to acute brain injury in humans.

Authors:  Martin Lauritzen; Anthony J Strong
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

3.  Ketamine reduces deleterious consequences of spreading depolarizations.

Authors:  Katelyn M Reinhart; C William Shuttleworth
Journal:  Exp Neurol       Date:  2018-04-10       Impact factor: 5.330

4.  Spreading depolarization in acute brain injury inhibited by ketamine: a prospective, randomized, multiple crossover trial.

Authors:  Andrew P Carlson; Mohammad Abbas; Robert L Alunday; Fares Qeadan; C William Shuttleworth
Journal:  J Neurosurg       Date:  2018-05-25       Impact factor: 5.115

Review 5.  Chaos and commotion in the wake of cortical spreading depression and spreading depolarizations.

Authors:  Daniela Pietrobon; Michael A Moskowitz
Journal:  Nat Rev Neurosci       Date:  2014-06       Impact factor: 34.870

6.  The use of spreading depression waves for acute and long-term monitoring of the penumbra zone of focal ischemic damage in rats.

Authors:  V I Koroleva; J Bures
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

7.  The neurobiology of migraine.

Authors:  Andrew Charles; K C Brennan
Journal:  Handb Clin Neurol       Date:  2010

8.  Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor complex.

Authors:  T P Obrenovitch; E Zilkha
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

9.  P/Q Ca2+ channel blockade stops spreading depression and related pyramidal neuronal Ca2+ rise in hippocampal organ culture.

Authors:  Phillip E Kunkler; Richard P Kraig
Journal:  Hippocampus       Date:  2004       Impact factor: 3.899

10.  Ketamine modulation of the haemodynamic response to spreading depolarization in the gyrencephalic swine brain.

Authors:  Renán Sánchez-Porras; Edgar Santos; Michael Schöll; Kevin Kunzmann; Christian Stock; Humberto Silos; Andreas W Unterberg; Oliver W Sakowitz
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.